Order Article Reprints

Bartsch DK, Gercke N, Strauch K, Wieboldt R, Matthäi E, Wagner V, Rospleszcz S, Schäfer A, Franke FS, Mintziras I, et al. The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer. Journal of Clinical Medicine. 2018; 7(10):295. https://doi.org/10.3390/jcm7100295

Bartsch, Detlef K., Norman Gercke, Konstantin Strauch, Ronja Wieboldt, Elvira Matthäi, Vinona Wagner, Susanne Rospleszcz, Agnes Schäfer, Frederike S. Franke, Ioannis Mintziras, and et al. 2018. "The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer" Journal of Clinical Medicine 7, no. 10: 295. https://doi.org/10.3390/jcm7100295

Bartsch, D. K., Gercke, N., Strauch, K., Wieboldt, R., Matthäi, E., Wagner, V., Rospleszcz, S., Schäfer, A., Franke, F. S., Mintziras, I., Bauer, C., Grote, T., Figiel, J., Di Fazio, P., Burchert, A., Reinartz, S., Pogge von Strandmann, E., Klöppel, G., & Slater, E. P. (2018). The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer. Journal of Clinical Medicine, 7(10), 295. https://doi.org/10.3390/jcm7100295